AIDS Healthcare Foundation, an organization that operates free AIDS treatment clinics around the world, praised drug giant Bristol-Myers Squibb’s decision to suspend direct-to-consumer advertising for any of its new drugs for at least one year.
DTC pharmaceutical ads make heavy use of direct response television and space.
“We applaud Bristol-Myers Squibb today for its commitment to pull direct-to-consumer ads for its new drugs,” said president Michael Weinstein in a statement. “While this is a welcome step in the right direction and we encourage other drug companies to follow BMS’ lead, we ultimately would like to see all drug advertising be ‘help-seeking’ messages — unbranded outreach — designed to encourage consumers to consult with their health care providers rather than sell specific drugs.”
